langtidssikkerhedsdataene blev sammenlignet med en fælles behandlingsgruppe af samlede lovastatin -, simvastatin -, fluvastatin - og pravastatindata.
As can be seen from table 3, following short term treatment, elevations of CPK > 10xULN are similar for patients treated with cerivastatin at doses between 0.2mg and 0.4mg but there is a 7-fold increase for patients treated with 0.8mg.